Buy KOSELUGO 25 mg/1 SELUMETINIB

Koselugo 25 mg capsules are a medication used to manage specific conditions. This oral treatment is designed to support therapeutic needs, offering a targeted approach.

Strength

25 mg/1

Pack Size

28 CAPSULE in 1 BOTTLE (0310-0625-28)

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Koselugo 25 mg capsules are primarily used for the treatment of neurofibromatosis type 1 (NF1) in pediatric patients. This medication is indicated for symptomatic, inoperable plexiform neurofibromas. It is important to consult with a healthcare provider to determine if Koselugo is suitable for your specific condition.

Side Effects

Common effects of Koselugo 25 mg capsules may include gastrointestinal issues such as diarrhea, nausea, and vomiting. Some patients may also experience fatigue, skin reactions, or changes in blood pressure. Always monitor your body's response and report any severe or persistent effects to your healthcare provider.

Precautions & Warnings

Koselugo 25 mg capsules should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Keep the capsules out of reach of children and pets. Always follow the instructions provided by your healthcare provider regarding the administration and storage of this medication.

Avoid Interactions

Koselugo 25 mg capsules may interact with certain medications, including those that are metabolized by the liver's cytochrome P450 enzymes. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions. Avoid consuming alcohol while taking this medication unless advised otherwise by your healthcare provider.

References

Frequently Asked Questions

Koselugo is used to treat symptomatic, inoperable plexiform neurofibromas in pediatric patients with neurofibromatosis type 1 (NF1).

Koselugo should be taken orally, typically twice daily, with or without food. Follow the specific instructions provided by your healthcare provider.

Common side effects may include gastrointestinal issues, fatigue, and skin reactions. Always consult your healthcare provider for personalized advice.

It is generally advised to avoid alcohol while taking Koselugo unless your healthcare provider specifies otherwise.

Store Koselugo in a cool, dry place away from direct sunlight and keep it out of reach of children and pets.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.